Search clinical trials for: Fenofibrate (drug)

Total 257349 results

Medical University of Silesia

Unknown

The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines (MSF)

Inflammation | Diabetes | Dyslipidemia | Cytokines

Poland
Alessandro Doria
University of Michigan; University of Minnesota

Recruiting

A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes (PERL-FENO)

Diabetic Nephropathies

United States
Indonesia University

Completed

Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume

Diabetes Mellitus | Diabetic Retinopathy | Dyslipidemias
Zydus Lifesciences Limited

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia

Dyslipidemia | Hypertriglyceridemia

India
University of California, Irvine

Completed

Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease

Huntington Disease

United States
Solvay Pharmaceuticals

Terminated

Effect of Fenofibrate on Sleep Apnea Syndrome

Obesity | Overweight | Dyslipidemia | Sleep Apnea Syndrome

France
Seoul National University Bundang Hospital
Daewon Pharmaceutical Co., Ltd.

Recruiting

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Diabetes Mellitus, Type 2 | Atherosclerosis | Dyslipidemia

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

Complex-dyslipidemia
Ain Shams University

Completed

Role of Fenofibrate in Neonatal Jaundice

Neonatal Jaundice

Egypt
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Dyslipidemia
University of Pennsylvania

Completed

Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate

Covid19

United States
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

Primary Biliary Cirrhosis

China
VA Office of Research and Development

Completed

Fenofibrate Treatment in SCI

Dyslipidemia | Spinal Cord Injury

United States
University of Arkansas
National Institutes of Health (NIH)

Withdrawn

Tissue Lipids and Insulin Resistance

Tissue Lipid Metabolism
Aegerion Pharmaceuticals, Inc.

Completed

Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS

Hyperlipidemia

United States
Laboratorios Silanes S.A. de C.V.

Recruiting

Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.

Dyslipidemia Associated With Type II Diabetes Mellitus

Mexico
Alaa Hassan ElBaz

Unknown

Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients

Diabetic Retinopathy
AbbVie (prior sponsor, Abbott)

Completed

Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood (FIRST)

Coronary Artery Disease | Dyslipidemia | Coronary Heart Disease

United States
Mutual Pharmaceutical Company, Inc.

Completed

Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)

Healthy

United States
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

China
University of Sydney
National Health and Medical Research Council, Australia; Mylan Pharmaceuticals... and other collaborators

Recruiting

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. (FAME 1 EYE)

Diabetic Retinopathy | Diabetic Nephropathies | Type 1 Diabetes Mellitus

Australia, Hong Kong, New Zealand, United Kingdom
Medical University of South Carolina

Completed

Fenofibrate in Type 2 Diabetes

Diabetes Mellitus, Type II

United States
Pfizer

Withdrawn

Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033

Obesity
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

Primary Biliary Cholangitis

China
Mayo Clinic

Recruiting

A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation (FICsDCD)

Liver Transplant

United States
McGill University Health Centre/Research Institute...

Completed

High-Density Lipoprotein (HDL) Treatment Study

Genetic Diseases, Inborn | Coronary Arteriosclerosis | Hypoalphalipoproteinemias

Canada
National Institute of Allergy and Infectious Diseases...

Completed

The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)

HIV Infections | Hypertriglyceridemia

United States
Piedmont Healthcare

Terminated

AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis (AFRICA)

Coronary Atherosclerosis

United States
Han Ying

Recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

Primary Biliary Cholangitis

China
The Lowy Medical Research Institute Limited

Active, not recruiting

Serine and Fenofibrate Study in Patients With MacTel Type 2 (SAFE)

Macular Telangiectasia Type 2

United States, United Kingdom
Hanlim Pharm. Co., Ltd.

Completed

Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin

Healthy Male Volunteers

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337

Dyslipidemias

Korea, Republic of
Keogh Institute for Medical Research

Completed

High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone (TibFen)

HDL Cholesterol

Australia
The University of Texas Medical Branch, Galveston
Shriners Hospitals for Children

Terminated

Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients

Second or Third Degree Burns

United States
Daewon Pharmaceutical Co., Ltd.

Unknown

Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy

Dyslipidemias

Korea, Republic of
University of Miami

Terminated

Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma

Multiple Myeloma

United States
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Dyslipidemias

Korea, Republic of
Tanta University
Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University; Hend El-Said Abo... and other collaborators

Recruiting

Fenofibrate in Ulcerative Colitis

Inflammatory Bowel Diseases

Egypt
Kowa Research Institute, Inc.

Completed

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

Severe Hypertriglyceridemia

United States, Czechia, Belarus, Hungary, Russian Federation, Poland, Bulgaria, Georgia, Ukraine
Gilead Sciences

Completed

Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function (HI)

Nonalcoholic Steatohepatitis (NASH)

United States
AstraZeneca

Terminated

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

Type 2 Diabetes

Brazil, France, Russian Federation, South Africa, Germany, Malaysia, Finland, Norway, Hong Kong, Canada, Hungary, Portugal, Taiwan, India, Philippines, Switzerland, Indonesia, Singapore
Hospices Civils de Lyon

Terminated

Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE) (ESYBRECHE)

Post-dural Puncture Headache

France
Abbott

Completed

Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

Dyslipidemias | Coronary Heart Disease | Mixed Dyslipidemia | Combined (Atherogenic) Dyslipidemia

United States
University of Ioannina

Unknown

Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia

Dyslipidemia

Greece
Solvay Pharmaceuticals

Terminated

Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study

Type 2 Diabetes | Dyslipidemia

Finland, Ireland, Italy
University of Alabama at Birmingham
Tufts University; University of Minnesota

Completed

Predictors of Response to Fenofibrate (PreFar)

Insulin Resistance | Hypertriglyceridemia

United States
Cairo University

Completed

Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis

Fenofibrate/Simvastatin Comparison
Lindsay Ferguson, MD

Not yet recruiting

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

Cervical Intraepithelial Neoplasia | Invasive Cervical Cancer
Chong Kun Dang Pharmaceutical

Completed

CKD-337 Drug Interaction Study

Dyslipidemia (Fredrickson Type Ⅱa) | Dyslipidemia (Fredrickson Type Ⅱb)

Korea, Republic of
Stanford University
Abbott

Completed

Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.

Insulin Resistance | Hypertriglyceridemia

United States

Search clinical trials for: Fenofibrate (drug)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations